KT203

General

Type : Piperidine,Triazol

Chemical_Nomenclature : 3-[4-[1-(2-benzylpiperidine-1-carbonyl)triazol-4-yl]phenyl]benzoic acid

Canonical SMILES : C1CCN(C(C1)CC2=CC=CC=C2)C(=O)N3C=C(N=N3)C4=CC=C(C=C4)C5=CC(=CC=C5)C(=O)O

InChI : InChI=1S\/C28H26N4O3\/c33-27(34)24-10-6-9-23(18-24)21-12-14-22(15-13-21)26-19-32(30-29-26)28(35)31-16-5-4-11-25(31)17-20-7-2-1-3-8-20\/h1-3,6-10,12-15,18-19,25H,4-5,11,16-17H2,(H,33,34)

InChIKey : SSSCOJOXPDDHOO-UHFFFAOYSA-N

Other name(s) : KT-203,CHEMBL3263582,MLS004256821


MW : 466.5

Formula : C28H26N4O3

CAS_number : 1402612-64-9

PubChem : 53364510

UniChem : SSSCOJOXPDDHOO-UHFFFAOYSA-N

IUPHAR :

Wikipedia :

Target

Families : KT203 ligand of proteins in family: ABHD6-Lip

Stucture :

Protein : human-ABHD6

References (5)

Title : Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach - Choudhary_2020_Front.Immunol_11_1664
Author(s) : Choudhary S , Malik YS , Tomar S
Ref : Front Immunol , 11 :1664 , 2020
Abstract : Choudhary_2020_Front.Immunol_11_1664
ESTHER : Choudhary_2020_Front.Immunol_11_1664
PubMedSearch : Choudhary_2020_Front.Immunol_11_1664
PubMedID: 32754161

Title : Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis - Manterola_2018_Neuropharmacol_141_181
Author(s) : Manterola A , Bernal-Chico A , Cipriani R , Ruiz A , Perez-Samartin A , Moreno-Rodriguez M , Hsu KL , Cravatt BF , Brown JM , Rodriguez-Puertas R , Matute C , Mato S
Ref : Neuropharmacology , 141 :181 , 2018
Abstract : Manterola_2018_Neuropharmacol_141_181
ESTHER : Manterola_2018_Neuropharmacol_141_181
PubMedSearch : Manterola_2018_Neuropharmacol_141_181
PubMedID: 30171986
Gene_locus related to this paper: human-ABHD6

Title : An in vivo multiplexed small-molecule screening platform - Gruner_2016_Nat.Methods_13_883
Author(s) : Gruner BM , Schulze CJ , Yang D , Ogasawara D , Dix MM , Rogers ZN , Chuang CH , McFarland CD , Chiou SH , Brown JM , Cravatt BF , Bogyo M , Winslow MM
Ref : Nat Methods , 13 :883 , 2016
Abstract : Gruner_2016_Nat.Methods_13_883
ESTHER : Gruner_2016_Nat.Methods_13_883
PubMedSearch : Gruner_2016_Nat.Methods_13_883
PubMedID: 27617390

Title : Comparative molecular field analysis and molecular dynamics studies of alpha\/beta hydrolase domain containing 6 (ABHD6) inhibitors - Kaczor_2015_J.Mol.Model_21_2789
Author(s) : Kaczor AA , Targowska-Duda KM , Patel JZ , Laitinen T , Parkkari T , Adams Y , Nevalainen TJ , Poso A
Ref : J Mol Model , 21 :2789 , 2015
Abstract : Kaczor_2015_J.Mol.Model_21_2789
ESTHER : Kaczor_2015_J.Mol.Model_21_2789
PubMedSearch : Kaczor_2015_J.Mol.Model_21_2789
PubMedID: 26350245

Title : Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of alpha\/beta-hydrolase domain containing 6 (ABHD6) - Hsu_2013_J.Med.Chem_56_8270
Author(s) : Hsu KL , Tsuboi K , Chang JW , Whitby LR , Speers AE , Pugh H , Cravatt BF
Ref : Journal of Medicinal Chemistry , 56 :8270 , 2013
Abstract : Hsu_2013_J.Med.Chem_56_8270
ESTHER : Hsu_2013_J.Med.Chem_56_8270
PubMedSearch : Hsu_2013_J.Med.Chem_56_8270
PubMedID: 24152295